| Literature DB >> 31756031 |
Jeffrey C Davis1,2, Aharon Helman1,2, José Rivera-Feliciano1,2, Christine M Langston1,2, Elise N Engquist1,2, Douglas A Melton1,2,3.
Abstract
Our laboratory and others have developed protocols to generate glucose-responsive stem cell-derived β cells in vitro. The cells resulting from these protocols could supplement or replace the use of human cadaveric islets for cell-based therapy for diabetes. The combination of an unlimited supply of pluripotent stem cell-derived β cells and gene-editing approaches will facilitate numerous in vitro studies not possible with cadaveric islets. Here, we describe a protocol for fluorescent labeling and isolation of stem cell-derived β cells. This purification of SC-β cells is based on intracellular zinc content and is a simple method to complement other approaches for generating and assaying these cells.Entities:
Keywords: SC-β cell enrichment; intracellular zinc content; stem cell-derived β (SC-β) cell
Year: 2019 PMID: 31756031 PMCID: PMC6876704 DOI: 10.1002/cpsc.99
Source DB: PubMed Journal: Curr Protoc Stem Cell Biol ISSN: 1938-8969
Figure 1Analysis of SC‐β cells before and after enrichment and reaggregation using TSQ‐based FACS. (A) Flow cytometry analysis of 1016 INSmCherry knock‐in reporter line without sorting for mCherry expression (left) and TSQ live cell staining (right). (B) Analysis of mCherry expression in TSQ High (left) and TSQ Low (right) subpopulations. (C) Dithiazone staining of human cadaveric islets (left), unsorted SC‐β cells (middle), and reaggregated, TSQ‐enriched SC‐β cells (right) 72 hr post‐sort. Light microscopy images were taken at 2.5× on a dissecting light microscope.